Join us for a virtual press conference with the U.S. Food and Drug Administration to discuss the FDA’s emergency use authorization of the Pfizer-BioNTech COV…
The FDA is announcing a pilot program aimed to help further accelerate the development of rare disease therapies.
I recently had the privilege of official travel to the European Union with our global affairs team.
Stroke is the fifth leading cause of death and a leading cause of serious disability in the United States.
I recently had the privilege of official travel to the U.K. with our global affairs team.
Highlights monthly webcast presentations for CE credit by FDA scientists from across agency on their cutting-edge scientific research
